70 results
8-K
EX-10.1
2kbk9vkbxxhoi
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-10.1
3g2wy
4 Jun 21
Entry into a Material Definitive Agreement
4:44pm
8-K
EX-10.1
owf2 nv3wi
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-10.1
6j20f 1sh
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
3wpdjp0skl9s
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-10.1
hupr8gn8s9f0bw
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-2.1
4g1ue01
14 Apr 14
Entry into a Material Definitive Agreement
12:00am